{"id":"betamethasone-dipropionate-0-05-cream","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Skin irritation"},{"rate":"5-10%","effect":"Allergic contact dermatitis"},{"rate":"5-10%","effect":"Folliculitis"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"It works by inhibiting the production of inflammatory mediators and reducing the activity of immune cells. This leads to a decrease in swelling, redness, and pain in affected areas.","oneSentence":"Betamethasone dipropionate is a corticosteroid that reduces inflammation and suppresses the immune system.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T03:58:03.746Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Seborrheic dermatitis"},{"name":"Psoriasis"}]},"trialDetails":[{"nctId":"NCT05981118","phase":"PHASE2, PHASE3","title":"Comparison of Post-Inflammatory Pigment Alteration After Psoriasis Treatment (PIPA - Dermavant)","status":"ENROLLING_BY_INVITATION","sponsor":"Wake Forest University Health Sciences","startDate":"2024-07-15","conditions":"ICD10 Code L40.9 for Psoriasis","enrollment":40},{"nctId":"NCT02376049","phase":"PHASE1","title":"A Clinical Trial to Compare Topical Agents in Adults With Mild to Moderate Atopic Dermatitis (AD)","status":"COMPLETED","sponsor":"LEO Pharma","startDate":"2015-02","conditions":"Atopic Dermatitis","enrollment":30},{"nctId":"NCT00820950","phase":"PHASE2","title":"A Study of Ruxolitinib Phosphate Cream When Applied to Patients With Plaque Psoriasis","status":"COMPLETED","sponsor":"Incyte Corporation","startDate":"2007-05-31","conditions":"Psoriasis","enrollment":29},{"nctId":"NCT00800293","phase":"","title":"Randomized Study to Compare the Bioavailability of Two Augmented Betamethasone Dipropionate 0.05% Topical Creams","status":"COMPLETED","sponsor":"Padagis LLC","startDate":"2002-12","conditions":"Healthy","enrollment":116},{"nctId":"NCT04444726","phase":"NA","title":"Phototherpy Versus Tapwater Iontophoresis for Management of Atopic Dermatitis in Children.","status":"COMPLETED","sponsor":"Cairo University","startDate":"2019-01-20","conditions":"Atopic Dermatitis","enrollment":60},{"nctId":"NCT03758365","phase":"PHASE1","title":"Evaluation of the Vasoconstriction Properties of MC2-01 Cream","status":"COMPLETED","sponsor":"MC2 Therapeutics","startDate":"2018-11-05","conditions":"Vasoconstriction","enrollment":36},{"nctId":"NCT02973776","phase":"PHASE1","title":"Vasoconstriction Trial With LEO 90100 Aerosol Foam","status":"COMPLETED","sponsor":"LEO Pharma","startDate":"2016-12","conditions":"Psoriasis Vulgaris","enrollment":36},{"nctId":"NCT02940002","phase":"PHASE1","title":"BAY1003803 Formulation Comparison in Open Psoriasis Plaque Test","status":"COMPLETED","sponsor":"Bayer","startDate":"2016-10-12","conditions":"Psoriasis","enrollment":23}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":14,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Betamethasone Dipropionate"],"phase":"phase_2","status":"active","brandName":"Betamethasone Dipropionate 0.05% Cream","genericName":"Betamethasone Dipropionate 0.05% Cream","companyName":"Padagis LLC","companyId":"padagis-llc","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Betamethasone dipropionate is a corticosteroid that reduces inflammation and suppresses the immune system. Used for Seborrheic dermatitis, Psoriasis.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":1},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}